The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (Gloria)
The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Comparing the Cost-effectiveness and Safety of Additional Low-dose Glucocorticoid in Treatment Strategies for Elderly Patients With Rheumatoid Arthritis
Sponsor: Amsterdam UMC, location VUmc
Listed as NCT02585258, this PHASE4 trial focuses on RheumatoId Arthritis and remains completed. Sponsored by Amsterdam UMC, location VUmc, it has been updated 13 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE4
-
May 2022 — Aug 2023 [monthly]
Completed PHASE4
▶ Show 8 earlier versions
-
Sep 2021 — May 2022 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Dec 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Dec 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- European Commission
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alkmaar, Netherlands , Amersfoort, Netherlands , Amsterdam, Netherlands , Apeldoorn, Netherlands , Berlin, Germany , Bratislava, Slovakia , Bucharest, Romania , Coimbra, Portugal , Debrecen, Hungary , Genova, Italy and 15 more locations